Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Certain growth factors can promote hair growth in mice by activating hair growth-related proteins.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Finasteride and minoxidil work best together for hair loss.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Suppressing certain hormones might help prevent prostate cancer.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.